Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXL-1020 in Patients With Systolic Heart Failure
NCT01096043Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CXL-1020, sponsored by Bristol Myers Squibb. Started Apr 2010; status: completed.
02
Drugs
CXL-1020
Beyond the preview
Go deeper on NCT01096043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096043.